Skip to main content
Premium Trial:

Request an Annual Quote

Plasticell, Stemnion Team on Stem Cell Differentiation Protocols

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plasticell today said that it has been collaborating with regenerative medicine firm Stemnion to develop protocols for stem cell differentiation.

UK-based Plasticell used its CombiCult technology to discover "multiple novel, serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages." Plasticell ranked the protocols using Ariadne's bioinformatics software, and Stemnion validated the protocols.

"Stemnion provided us with a challenge that is typical of adult stem cell R&D programs, however this project was particularly interesting on several fronts, including for the first time utilizing placenta-delivered stem cells as the starting stem cell type," Lilian Hook, director of research at Plasticell, said in a statement.

Financial and other terms of the collaboration were not disclosed.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.